Knowledge Center
Article / Jun 08, 2009
Hovione Shapes China Manufacturing Site
Source:
C&EN, 8 June, 2009
Hovione may have made itself a name as a first-class manufacturer of regulated active pharmaceutical ingredients (APIs), but it still needs to compete on price for some of its business. As in many industries, one of the best ways to lower cost is to have a manufacturing base in China. That is what Hovione did in March 2008 when it acquired a 75% stake in Hisyn Pharmaceutical, an API manufacturer in Taizhou, Zhejiang province. The site is a four-hour drive from Shanghai.
Related links
Also in the Knowledge Center
/ Oct 19, 2026
A dimensionless framework for hold-up mass prediction and scale transfer in continuous linear blending
Read more
Scientific Article
/ Oct 26, 2026
Streamlined development of continuous blending through integrated process understanding and predictive modeling
Read more
Scientific Article
/ Aug 04, 2026
Hovione: Accelerating Oral Drug Development Through Rapid Prototyping and Integrated Development Strategies
Read more
Scientific Article